Erba Diagnostics Inc (ERB) 0.56 $ERB ERBA Diagn
Post# of 273322
Posted On: 09/20/2016 9:13:07 AM
Erba Diagnostics Inc (ERB) 0.56 $ERB
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
GlobeNewswire - Fri Aug 26, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE:ERB) (the "Company"
, a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has determined that the Company is not in compliance with Sections 134 and 1101 of the Exchange's Company Guide (the "Company Guide" due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 with the Securities and Exchange Commission. The letter also states that the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 is a material violation of its listing agreement with the Exchange and, therefore, pursuant to Section 1003(d) of the Company Guide, the Exchange is authorized to suspend and, unless prompt corrective action is taken, remove the Company's securities from the Exchange.
ERB: 0.56 (+0.02)
ERBA Diagnostics, Inc. Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
GlobeNewswire - Tue May 31, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company" , a fully integrated in vitro diagnostics company, announced today that it has entered into an amendment to employment agreement with Mohan Gopalkrishnan, the Company's Chief Executive Officer, which extended Mr. Mohan's term of employment for seven (7) months, such that his contract term will now expire on December 31, 2016.
TRIB: 12.99 (-0.23), ERB: 0.56 (+0.02)
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
GlobeNewswire - Fri May 20, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company" , a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has determined that the Company is not in compliance with Sections 134 and 1101 of the Exchange's Company Guide (the "Company Guide" due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 with the Securities and Exchange Commission. The letter also states that the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 is a material violation of its listing agreement with the Exchange and, therefore, pursuant to Section 1003(d) of the Company Guide, the Exchange is authorized to suspend and, unless prompt corrective action is taken, remove the Company's securities from the Exchange.
ERB: 0.56 (+0.02)
DEADLINE TODAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Mon Feb 01, 11:13AM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT: ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016
ACCESSWIRE - Mon Feb 01, 9:00AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed on behalf of those who purchased shares of ERBA Diagnostics, Inc. ("ERBA" or the "Company" (NYSE MKT: ERB), during the period between April 14, 2014 and November 20, 2015 inclusive (the "Class Period" .
ERB: 0.56 (+0.02)
DEADLINE NOTICE: Scott + Scott, LLP Reminds Investors of Monday, February 1, 2016 Lead Plaintiff Deadline in the ERBA Diagnostics, Inc. Securities Lawsuit
BusinessWire - Sun Jan 31, 2:59PM CST
Scott + Scott, LLP, a global investor rights law firm, reminds investors that Monday, February 1, 2016 is the deadline for filing lead plaintiff papers in the securities lawsuit against ERBA Diagnostics, Inc. (ERB). To get information on filing lead plaintiff papers, or to join the lawsuit, go to: http://www.scott-scott.com/pop.php?page=join&...se_id=2714. There is no cost or obligation to you.
ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - ERB
PR Newswire - Fri Jan 29, 1:43PM CST
Pomerantz LLP announces that a class action lawsuit has been filed against ERBA Diagnostics, Inc. ("ERBA" or the "Company" (NYSE MKT: ERB) and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, and docketed under 15-cv-24425, is on behalf of a class consisting of all persons or entities who purchased ERBA securities between April 14, 2014 and November 23, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Fri Jan 29, 12:48PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
ERB: 0.56 (+0.02)
ERBA Diagnostics' Compliance Plan Accepted by NYSE MKT
GlobeNewswire - Wed Jan 27, 7:00AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company" , a fully integrated in vitro diagnostics company, announced today that the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has accepted the Company's plan of compliance (the "Plan" for continued listing relating to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015.
ERB: 0.56 (+0.02)
INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016 -- ERB
PR Newswire - Mon Jan 25, 3:20PM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT: ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ERBA Diagnostics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ERB
GlobeNewswire - Mon Jan 25, 12:05PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of ERBA Diagnostics, Inc. (NYSE MKT:ERB) ("ERBA" or the "Company" securities during the period between April 14, 2014 and November 23, 2015, inclusive (the "Class Period" . Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until February 1, 2016 to seek appointment as lead plaintiff.
ERB: 0.56 (+0.02)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 - ERB
GlobeNewswire - Wed Jan 20, 12:23PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
ERB: 0.56 (+0.02)
Lawsuit for Investors in ERBA Diagnostics Inc (NYSEMKT:ERB) Shares Announced by Shareholders Foundation
GlobeNewswire - Wed Jan 20, 10:05AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed in Florida on behalf of certain purchasers of shares of ERBA Diagnostics Inc (NYSEMKT:ERB) over alleged Securities Laws Violations by ERBA Diagnostics.
ERB: 0.56 (+0.02)
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016
ACCESSWIRE - Wed Jan 20, 9:02AM CST
NEW YORK, NY / ACCESSWIRE / January 20, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court for the Southern District of Florida on behalf of those who purchased shares of ERBA Diagnostics, Inc. ("ERBA" or the "Company" (NYSE MKT: ERB), during the period between April 14, 2014 and November 23, 2015 inclusive. (the "Class Period" .
ERB: 0.56 (+0.02)
Lifshitz & Miller Law Firm Announces Investigation of BofI Holding, Inc., Capstone Turbine Corporation, Dr. Reddy's Laboratories Ltd., ERBA Diagnostics, Inc., Identiv, Inc., Osiris Therapeutics, Inc., and XBiotech Inc.
PR Newswire - Mon Jan 18, 1:29PM CST
BofI Holding, Inc. (BOFI)
BOFI: 22.19 (-0.19), XBIT: 13.31 (-0.28), INVE: 2.11 (+0.04), CPST: 1.33 (-0.07), OSIR: 4.98 (-0.06), RDY: 46.99 (+0.24), ERB: 0.56 (+0.02)
ERB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Mon Jan 18, 9:51AM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT:ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - ERB
GlobeNewswire - Mon Jan 18, 7:00AM CST
Pomerantz LLP announces that a class action lawsuit has been filed against ERBA Diagnostics, Inc. ("ERBA" or the "Company" (NYSE:ERB) and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, and docketed under 15-cv-24425, is on behalf of a class consisting of all persons or entities who purchased ERBA securities between April 14, 2014 and November 23, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
ERB: 0.56 (+0.02)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of ERBA Diagnostics, Inc. of Upcoming Deadline -- ERB
GlobeNewswire - Fri Jan 15, 1:29PM CST
Rigrodsky & Long, P.A.:
ERB: 0.56 (+0.02)
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
GlobeNewswire - Fri Aug 26, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE:ERB) (the "Company"
, a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has determined that the Company is not in compliance with Sections 134 and 1101 of the Exchange's Company Guide (the "Company Guide" due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 with the Securities and Exchange Commission. The letter also states that the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 is a material violation of its listing agreement with the Exchange and, therefore, pursuant to Section 1003(d) of the Company Guide, the Exchange is authorized to suspend and, unless prompt corrective action is taken, remove the Company's securities from the Exchange. ERB: 0.56 (+0.02)
ERBA Diagnostics, Inc. Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
GlobeNewswire - Tue May 31, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company"
, a fully integrated in vitro diagnostics company, announced today that it has entered into an amendment to employment agreement with Mohan Gopalkrishnan, the Company's Chief Executive Officer, which extended Mr. Mohan's term of employment for seven (7) months, such that his contract term will now expire on December 31, 2016. TRIB: 12.99 (-0.23), ERB: 0.56 (+0.02)
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
GlobeNewswire - Fri May 20, 3:15PM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company"
, a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has determined that the Company is not in compliance with Sections 134 and 1101 of the Exchange's Company Guide (the "Company Guide" due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 with the Securities and Exchange Commission. The letter also states that the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 is a material violation of its listing agreement with the Exchange and, therefore, pursuant to Section 1003(d) of the Company Guide, the Exchange is authorized to suspend and, unless prompt corrective action is taken, remove the Company's securities from the Exchange. ERB: 0.56 (+0.02)
DEADLINE TODAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Mon Feb 01, 11:13AM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT: ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016
ACCESSWIRE - Mon Feb 01, 9:00AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed on behalf of those who purchased shares of ERBA Diagnostics, Inc. ("ERBA" or the "Company"
(NYSE MKT: ERB), during the period between April 14, 2014 and November 20, 2015 inclusive (the "Class Period" . ERB: 0.56 (+0.02)
DEADLINE NOTICE: Scott + Scott, LLP Reminds Investors of Monday, February 1, 2016 Lead Plaintiff Deadline in the ERBA Diagnostics, Inc. Securities Lawsuit
BusinessWire - Sun Jan 31, 2:59PM CST
Scott + Scott, LLP, a global investor rights law firm, reminds investors that Monday, February 1, 2016 is the deadline for filing lead plaintiff papers in the securities lawsuit against ERBA Diagnostics, Inc. (ERB). To get information on filing lead plaintiff papers, or to join the lawsuit, go to: http://www.scott-scott.com/pop.php?page=join&...se_id=2714. There is no cost or obligation to you.
ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - ERB
PR Newswire - Fri Jan 29, 1:43PM CST
Pomerantz LLP announces that a class action lawsuit has been filed against ERBA Diagnostics, Inc. ("ERBA" or the "Company"
(NYSE MKT: ERB) and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, and docketed under 15-cv-24425, is on behalf of a class consisting of all persons or entities who purchased ERBA securities between April 14, 2014 and November 23, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Fri Jan 29, 12:48PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
ERB: 0.56 (+0.02)
ERBA Diagnostics' Compliance Plan Accepted by NYSE MKT
GlobeNewswire - Wed Jan 27, 7:00AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company"
, a fully integrated in vitro diagnostics company, announced today that the Company received a letter from NYSE MKT LLC (the "Exchange" stating that the Exchange has accepted the Company's plan of compliance (the "Plan" for continued listing relating to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015. ERB: 0.56 (+0.02)
INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016 -- ERB
PR Newswire - Mon Jan 25, 3:20PM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT: ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ERBA Diagnostics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ERB
GlobeNewswire - Mon Jan 25, 12:05PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of ERBA Diagnostics, Inc. (NYSE MKT:ERB) ("ERBA" or the "Company"
securities during the period between April 14, 2014 and November 23, 2015, inclusive (the "Class Period" . Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until February 1, 2016 to seek appointment as lead plaintiff. ERB: 0.56 (+0.02)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 - ERB
GlobeNewswire - Wed Jan 20, 12:23PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
ERB: 0.56 (+0.02)
Lawsuit for Investors in ERBA Diagnostics Inc (NYSEMKT:ERB) Shares Announced by Shareholders Foundation
GlobeNewswire - Wed Jan 20, 10:05AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed in Florida on behalf of certain purchasers of shares of ERBA Diagnostics Inc (NYSEMKT:ERB) over alleged Securities Laws Violations by ERBA Diagnostics.
ERB: 0.56 (+0.02)
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016
ACCESSWIRE - Wed Jan 20, 9:02AM CST
NEW YORK, NY / ACCESSWIRE / January 20, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court for the Southern District of Florida on behalf of those who purchased shares of ERBA Diagnostics, Inc. ("ERBA" or the "Company"
(NYSE MKT: ERB), during the period between April 14, 2014 and November 23, 2015 inclusive. (the "Class Period" . ERB: 0.56 (+0.02)
Lifshitz & Miller Law Firm Announces Investigation of BofI Holding, Inc., Capstone Turbine Corporation, Dr. Reddy's Laboratories Ltd., ERBA Diagnostics, Inc., Identiv, Inc., Osiris Therapeutics, Inc., and XBiotech Inc.
PR Newswire - Mon Jan 18, 1:29PM CST
BofI Holding, Inc. (BOFI)
BOFI: 22.19 (-0.19), XBIT: 13.31 (-0.28), INVE: 2.11 (+0.04), CPST: 1.33 (-0.07), OSIR: 4.98 (-0.06), RDY: 46.99 (+0.24), ERB: 0.56 (+0.02)
ERB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016
BusinessWire - Mon Jan 18, 9:51AM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT:ERB) securities between April 14, 2014 and November 20, 2015.
ERB: 0.56 (+0.02)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - ERB
GlobeNewswire - Mon Jan 18, 7:00AM CST
Pomerantz LLP announces that a class action lawsuit has been filed against ERBA Diagnostics, Inc. ("ERBA" or the "Company"
(NYSE:ERB) and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, and docketed under 15-cv-24425, is on behalf of a class consisting of all persons or entities who purchased ERBA securities between April 14, 2014 and November 23, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . ERB: 0.56 (+0.02)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of ERBA Diagnostics, Inc. of Upcoming Deadline -- ERB
GlobeNewswire - Fri Jan 15, 1:29PM CST
Rigrodsky & Long, P.A.:
ERB: 0.56 (+0.02)
(0)
(0)